Analyst Ratings for Benitec BioPharma (BNTC)
BNTC Rating Summary
BNTC Price Target Summary
- Highest: $32.00 (H.C. Wainwright)
- Lowest: $24.00 (Citizens)
- Average: $28.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$28.00 (+119.1%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
Avg. $ Target:
$28.00 (+119.1%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/10/2026 | Guggenheim | Debjit Chattopadhyay | Downgrade | Neutral (Buy) |
N/A (N/A) |
10.81 (12.78) |
18.22% | Details |
| 5/12/2026 | Evercore ISI | Cory Kasimov | New Coverage | Outperform (N/A) |
25.00 (N/A) |
12.08 (12.78) |
5.79% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
